May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
Complications of a Surgeon’s Initial Intravitreal Injections
Author Affiliations & Notes
  • R. E. Frenkel
    Ophthalmology, East Florida Eye Institute, Stuart, Florida
  • L. Mani
    Ophthalmology, Eye Research Foundation, Stuart, Florida
  • A. Reyes
    Ophthalmology, Eye Research Foundation, Stuart, Florida
  • Footnotes
    Commercial Relationships  R.E. Frenkel, None; L. Mani, None; A. Reyes, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 253. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. E. Frenkel, L. Mani, A. Reyes; Complications of a Surgeon’s Initial Intravitreal Injections. Invest. Ophthalmol. Vis. Sci. 2008;49(13):253.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the incidence of complications secondary to a surgeon’s initial consecutive 345 intravitreal injections

Methods: : A retrospective study of a single surgeon’s first 345 intravitreal anti-VEGF injections, administered to exudative AMD patients was performed. 104 eyes received Macugen, 74 received Avastin, and 167 received Lucentis using different gauge needle. All patients received an average of 1 prophylactic medication one hour prior to the injections. Vision was evaluated immediately following injection.

Results: : All patients showed a significant increase in transient IOP 1" after injection which usually normalized by about 30" post-injection. 1 eye developed a lid swelling, 2 had transient pain during the injection, 1 eye acquired transient floaters, 1 eye suffered an RPE rip, 1 patient had corneal edema, and 1 got a corneal abrasion. There was a 4.8% (5/104) incidence of transient NLP following Macugen injections, while no patients went NLP following Avastin or Lucentis. None of the patients had retinal tear, heart attack, stroke, endophthalmitis, toxic reaction, traumatic cataracts, retinal detachment, or vitreous hemorrhage.

Conclusions: : Surgeons initial intravitreal injections can be very safely perform with only minimal complications.

Keywords: age-related macular degeneration • intraocular pressure 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.